• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·SPTX
Share

Seaport Therapeutics, Inc. Common Stock Stocks

$ 22.34Last Updated 05.08.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 1.15B

$ 22.34
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

01.05.2026 14:59

IPO of Seaport Therapeutics: shares of the antidepressant developer become available

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

07.08.2026 16:46

Papa John's stock has plummeted to a 14-year low. Why are investors selling it off?

07.08.2026 16:09

Iran's chief negotiator accused Trump of "theatrical diplomacy"

07.08.2026 15:30

From Antarctica to the Nasdaq: How Lindblad Expeditions Made a Fortune from a Love of the Wild

07.08.2026 15:14

Morning in New York: Hiring Trends Will Put the Tech Rally to the Test

07.08.2026 15:00

Latigo IPO: A "secret" biotech startup founded by former Amgen employees has gone public

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026